{"id":32822,"date":"2023-10-12T17:39:27","date_gmt":"2023-10-12T23:39:27","guid":{"rendered":"https:\/\/brakkeconsulting.com\/?p=32822"},"modified":"2023-10-12T17:40:15","modified_gmt":"2023-10-12T23:40:15","slug":"brakke-viewpoint-october-13-2023","status":"publish","type":"post","link":"https:\/\/brakkeconsulting.com\/pt\/brakke-viewpoint-october-13-2023\/","title":{"rendered":"Mirante de Brakke 13 de outubro de 2023"},"content":{"rendered":"<p>Uma das coisas fascinantes sobre a ind\u00fastria da sa\u00fade animal \u00e9 a oportunidade de crescimento atrav\u00e9s do desenvolvimento de novas tecnologias de sa\u00fade animal. E h\u00e1 oportunidades em todo o mundo \u2013 o Brasil \u00e9 um bom exemplo.<\/p>\n<p>O Brasil \u00e9 o quarto maior produtor de til\u00e1pia do mundo, produzindo 585 mil toneladas em 2022. A ind\u00fastria ainda \u00e9 jovem, com uma taxa de mortalidade de 40%. No entanto, apenas 25% de alevinos s\u00e3o vacinados contra as principais doen\u00e7as bacterianas e virais, incluindo <em>Estreptococo, Francisella<\/em>e ISKNv.<\/p>\n<p>O professor Henrique Figueiredo da UFMG, em sua apresenta\u00e7\u00e3o no Congresso Internacional de Pesca de 2023, identificou os seguintes desafios para o desenvolvimento da aquicultura de til\u00e1pia no Brasil:<\/p>\n<ul>\n<li>A necessidade de vacinas polivalentes<\/li>\n<li>O desenvolvimento de vacinas orais e de imers\u00e3o<\/li>\n<li>O desenvolvimento de vacinas que cubram as variantes antig\u00eanicas e gen\u00e9ticas de pat\u00f3genos circulantes<\/li>\n<li>Solu\u00e7\u00f5es tecnol\u00f3gicas para aplica\u00e7\u00e3o de vacinas em grandes popula\u00e7\u00f5es<\/li>\n<li>Melhores medidas de biosseguran\u00e7a e pr\u00e1ticas de gest\u00e3o<\/li>\n<li>O uso de outras tecnologias para reduzir o impacto de doen\u00e7as, como cepas tolerantes de til\u00e1pia, probi\u00f3ticos e prebi\u00f3ticos<\/li>\n<\/ul>\n<p>Desde o desenvolvimento de vacinas, tecnologia de distribui\u00e7\u00e3o de vacinas, melhoramentos gen\u00e9ticos, at\u00e9 produtos de sa\u00fade entregues em ra\u00e7\u00f5es \u2013 estas s\u00e3o algumas das oportunidades que temos pela frente para o avan\u00e7o dos peixes de aquicultura. Ah, e caso voc\u00ea n\u00e3o saiba, a Brakke oferece servi\u00e7os de consultoria para o mercado de til\u00e1pia. Basta perguntar.<\/p>\n<p><em>Mauri Ronan Moreira <\/em><\/p>","protected":false},"excerpt":{"rendered":"<p>Uma das coisas fascinantes sobre a ind\u00fastria da sa\u00fade animal \u00e9 a oportunidade de crescimento atrav\u00e9s do desenvolvimento de novas tecnologias de sa\u00fade animal. E h\u00e1 oportunidades em todo o mundo \u2013 o Brasil \u00e9 um bom exemplo. O Brasil \u00e9 o quarto maior produtor de til\u00e1pia do mundo, produzindo 585 mil toneladas em 2022. A ind\u00fastria ainda \u00e9 jovem, com uma taxa de mortalidade de 40%. No entanto, apenas 25% de alevinos s\u00e3o vacinados contra as principais doen\u00e7as bacterianas e virais, incluindo Streptococcus, Francisella e ISKNv. O professor Henrique Figueiredo da UFMG, em sua apresenta\u00e7\u00e3o no Congresso Internacional de Pesca de 2023, identificou os seguintes desafios para o desenvolvimento da aquicultura de til\u00e1pia no Brasil: A necessidade de vacinas polivalentes O desenvolvimento de vacinas orais e de imers\u00e3o O desenvolvimento de vacinas que cubram as caracter\u00edsticas antig\u00eanicas e variantes gen\u00e9ticas de pat\u00f3genos circulantes Solu\u00e7\u00f5es tecnol\u00f3gicas para a aplica\u00e7\u00e3o de vacinas em grandes popula\u00e7\u00f5es Medidas e pr\u00e1ticas de manejo melhoradas de biosseguran\u00e7a O uso de outras tecnologias para reduzir o impacto de doen\u00e7as, como cepas tolerantes de til\u00e1pia, probi\u00f3ticos e prebi\u00f3ticos Desde o desenvolvimento de vacinas, tecnologia de distribui\u00e7\u00e3o de vacinas , melhorias gen\u00e9ticas, at\u00e9 produtos de sa\u00fade entregues em ra\u00e7\u00f5es \u2013 estas s\u00e3o algumas das oportunidades que temos diante de n\u00f3s para o avan\u00e7o dos peixes de viveiro. Ah, e caso voc\u00ea n\u00e3o saiba, a Brakke oferece servi\u00e7os de consultoria para o mercado de til\u00e1pia. Basta perguntar. Mauri Ronan Moreira<\/p>","protected":false},"author":19,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":"","_links_to":"","_links_to_target":""},"categories":[43],"tags":[],"class_list":["post-32822","post","type-post","status-publish","format-standard","hentry","category-viewpoints"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.0 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>News from Brakke Consulting<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/brakkeconsulting.com\/pt\/brakke-viewpoint-october-13-2023\/\" \/>\n<meta property=\"og:locale\" content=\"pt_PT\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"News from Brakke Consulting\" \/>\n<meta property=\"og:description\" content=\"One of the fascinating things about the animal health industry is the opportunity for growth through developing new animal health technologies.\u00a0 And there are opportunities around the world &#8211; Brazil is a good example. Brazil is the fourth largest producer of tilapia in the world, producing 585,000 metric tons in 2022. The industry is still young, with a mortality rate of 40%. However, only 25% of fingerlings are vaccinated against major bacterial and viral diseases, including Streptococcus, Francisella, and ISKNv. Professor Henrique Figueiredo of UFMG, in his presentation at the 2023 International Fish Congress, identified the following challenges for the development of tilapia aquaculture in Brazil: The need for polyvalent vaccines The development of oral and immersion vaccines The development of vaccines that cover the antigenic and genetic variants of circulating pathogens Technological solutions for the application of vaccines to large populations Improved biosecurity measures and management practices The use of other technologies to reduce the impact of diseases, such as tolerant tilapia strains, probiotics, and prebiotics From vaccine development, vaccine delivery technology, genetic improvements, to health products delivered in feed \u2013 these are some of the opportunities in front of us for the advancement of farmed fish.\u00a0 Oh, and just in case you didn\u2019t know it, Brakke offers consulting services to the tilapia market.\u00a0 Just ask. Mauri Ronan Moreira\" \/>\n<meta property=\"og:url\" content=\"https:\/\/brakkeconsulting.com\/pt\/brakke-viewpoint-october-13-2023\/\" \/>\n<meta property=\"og:site_name\" content=\"Brakke Consulting Website\" \/>\n<meta property=\"article:published_time\" content=\"2023-10-12T23:39:27+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-10-12T23:40:15+00:00\" \/>\n<meta name=\"author\" content=\"Amanda McDavid\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"Amanda McDavid\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tempo estimado de leitura\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minuto\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/brakkeconsulting.com\/brakke-viewpoint-october-13-2023\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/brakkeconsulting.com\/brakke-viewpoint-october-13-2023\/\"},\"author\":{\"name\":\"Amanda McDavid\",\"@id\":\"https:\/\/brakkeconsulting.com\/#\/schema\/person\/cbd3330707aa1f20925a2f9d78722615\"},\"headline\":\"Brakke Viewpoint October 13, 2023\",\"datePublished\":\"2023-10-12T23:39:27+00:00\",\"dateModified\":\"2023-10-12T23:40:15+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/brakkeconsulting.com\/brakke-viewpoint-october-13-2023\/\"},\"wordCount\":218,\"articleSection\":[\"Viewpoints\"],\"inLanguage\":\"pt-PT\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/brakkeconsulting.com\/brakke-viewpoint-october-13-2023\/\",\"url\":\"https:\/\/brakkeconsulting.com\/brakke-viewpoint-october-13-2023\/\",\"name\":\"News from Brakke Consulting\",\"isPartOf\":{\"@id\":\"https:\/\/brakkeconsulting.com\/#website\"},\"datePublished\":\"2023-10-12T23:39:27+00:00\",\"dateModified\":\"2023-10-12T23:40:15+00:00\",\"author\":{\"@id\":\"https:\/\/brakkeconsulting.com\/#\/schema\/person\/cbd3330707aa1f20925a2f9d78722615\"},\"breadcrumb\":{\"@id\":\"https:\/\/brakkeconsulting.com\/brakke-viewpoint-october-13-2023\/#breadcrumb\"},\"inLanguage\":\"pt-PT\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/brakkeconsulting.com\/brakke-viewpoint-october-13-2023\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/brakkeconsulting.com\/brakke-viewpoint-october-13-2023\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/brakkeconsulting.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Brakke Viewpoint October 13, 2023\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/brakkeconsulting.com\/#website\",\"url\":\"https:\/\/brakkeconsulting.com\/\",\"name\":\"Brakke Consulting Website\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/brakkeconsulting.com\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"pt-PT\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/brakkeconsulting.com\/#\/schema\/person\/cbd3330707aa1f20925a2f9d78722615\",\"name\":\"Amanda McDavid\",\"url\":\"https:\/\/brakkeconsulting.com\/pt\/author\/amanda\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Not\u00edcias da Brakke Consulting","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/brakkeconsulting.com\/pt\/brakke-viewpoint-october-13-2023\/","og_locale":"pt_PT","og_type":"article","og_title":"News from Brakke Consulting","og_description":"One of the fascinating things about the animal health industry is the opportunity for growth through developing new animal health technologies.\u00a0 And there are opportunities around the world &#8211; Brazil is a good example. Brazil is the fourth largest producer of tilapia in the world, producing 585,000 metric tons in 2022. The industry is still young, with a mortality rate of 40%. However, only 25% of fingerlings are vaccinated against major bacterial and viral diseases, including Streptococcus, Francisella, and ISKNv. Professor Henrique Figueiredo of UFMG, in his presentation at the 2023 International Fish Congress, identified the following challenges for the development of tilapia aquaculture in Brazil: The need for polyvalent vaccines The development of oral and immersion vaccines The development of vaccines that cover the antigenic and genetic variants of circulating pathogens Technological solutions for the application of vaccines to large populations Improved biosecurity measures and management practices The use of other technologies to reduce the impact of diseases, such as tolerant tilapia strains, probiotics, and prebiotics From vaccine development, vaccine delivery technology, genetic improvements, to health products delivered in feed \u2013 these are some of the opportunities in front of us for the advancement of farmed fish.\u00a0 Oh, and just in case you didn\u2019t know it, Brakke offers consulting services to the tilapia market.\u00a0 Just ask. Mauri Ronan Moreira","og_url":"https:\/\/brakkeconsulting.com\/pt\/brakke-viewpoint-october-13-2023\/","og_site_name":"Brakke Consulting Website","article_published_time":"2023-10-12T23:39:27+00:00","article_modified_time":"2023-10-12T23:40:15+00:00","author":"Amanda McDavid","twitter_card":"summary_large_image","twitter_misc":{"Escrito por":"Amanda McDavid","Tempo estimado de leitura":"1 minuto"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/brakkeconsulting.com\/brakke-viewpoint-october-13-2023\/#article","isPartOf":{"@id":"https:\/\/brakkeconsulting.com\/brakke-viewpoint-october-13-2023\/"},"author":{"name":"Amanda McDavid","@id":"https:\/\/brakkeconsulting.com\/#\/schema\/person\/cbd3330707aa1f20925a2f9d78722615"},"headline":"Brakke Viewpoint October 13, 2023","datePublished":"2023-10-12T23:39:27+00:00","dateModified":"2023-10-12T23:40:15+00:00","mainEntityOfPage":{"@id":"https:\/\/brakkeconsulting.com\/brakke-viewpoint-october-13-2023\/"},"wordCount":218,"articleSection":["Viewpoints"],"inLanguage":"pt-PT"},{"@type":"WebPage","@id":"https:\/\/brakkeconsulting.com\/brakke-viewpoint-october-13-2023\/","url":"https:\/\/brakkeconsulting.com\/brakke-viewpoint-october-13-2023\/","name":"Not\u00edcias da Brakke Consulting","isPartOf":{"@id":"https:\/\/brakkeconsulting.com\/#website"},"datePublished":"2023-10-12T23:39:27+00:00","dateModified":"2023-10-12T23:40:15+00:00","author":{"@id":"https:\/\/brakkeconsulting.com\/#\/schema\/person\/cbd3330707aa1f20925a2f9d78722615"},"breadcrumb":{"@id":"https:\/\/brakkeconsulting.com\/brakke-viewpoint-october-13-2023\/#breadcrumb"},"inLanguage":"pt-PT","potentialAction":[{"@type":"ReadAction","target":["https:\/\/brakkeconsulting.com\/brakke-viewpoint-october-13-2023\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/brakkeconsulting.com\/brakke-viewpoint-october-13-2023\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/brakkeconsulting.com\/"},{"@type":"ListItem","position":2,"name":"Brakke Viewpoint October 13, 2023"}]},{"@type":"WebSite","@id":"https:\/\/brakkeconsulting.com\/#website","url":"https:\/\/brakkeconsulting.com\/","name":"Site da Brakke Consulting","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/brakkeconsulting.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"pt-PT"},{"@type":"Person","@id":"https:\/\/brakkeconsulting.com\/#\/schema\/person\/cbd3330707aa1f20925a2f9d78722615","name":"Amanda McDavid","url":"https:\/\/brakkeconsulting.com\/pt\/author\/amanda\/"}]}},"_links":{"self":[{"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/posts\/32822","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/users\/19"}],"replies":[{"embeddable":true,"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/comments?post=32822"}],"version-history":[{"count":1,"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/posts\/32822\/revisions"}],"predecessor-version":[{"id":32824,"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/posts\/32822\/revisions\/32824"}],"wp:attachment":[{"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/media?parent=32822"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/categories?post=32822"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/tags?post=32822"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}